ALX Oncology
ALXO
ALXO
61 hedge funds and large institutions have $12.6M invested in ALX Oncology in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 32 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-24
Holders Change %
-28.24%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
9
Reduced
32
Closed
34
Calls
$48K
Puts
$7K
Net Calls
+$41K
Net Calls Change
+$74K
Top Buyers
| 1 |
AC
Almitas Capital
Santa Monica,
California
|
+$492K |
| 2 |
Jane Street
New York
|
+$84.4K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$34K |
| 4 |
Renaissance Technologies
New York
|
+$29.5K |
| 5 |
Squarepoint
New York
|
+$24.2K |
Top Sellers
| 1 |
BlackRock
New York
|
-$663K |
| 2 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$343K |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
-$255K |
| 4 |
State Street
Boston,
Massachusetts
|
-$247K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$189K |
